Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mass antibiotic dosing could save thousands of children in niger

NCT ID NCT06358872

Recruiting now Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This trial investigates whether giving a single dose of azithromycin to children in rural Niger can lower death rates under age five. Over 3 million children are involved, with monitoring of both mortality and antimicrobial resistance. The study adapts every two years to refine the approach and assess long-term effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
azithromycin oral suspension
What this could lead to
If successful, this could provide a scalable strategy to reduce child mortality in rural Niger and similar settings.
What could go wrong
The trial is large but observational in parts, and increased antimicrobial resistance is a known risk that may limit long-term benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIMICROBIAL RESISTANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTIMICROBIAL RESISTANCE MORTALITY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Program National de Santé Oculaire

    RECRUITING

    Niamey, Niger

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.